Enterprise Products Partners (EPD), a major midstream energy company with over $80 billion in market value, has outperformed the S&P 500 by nearly 35% due to rising energy demand. The company's future growth depends on continued energy consumption, but shifts toward renewable energy policies could reduce asset use and revenue. Despite these risks, EPD remains a strong investment option, especially for retirement portfolios, though investors should be aware of the tax complexities of MLPs and the potential impact of the energy transition on returns.
Enterprise Products Partners stock is the subject of this update. For readers following energy-sector stocks, here is Pluang's market snapshot as of Sep 23, 2026 07:51 WIB: Out of 37 priced US energy stocks, 13 rose and 23 fell. Notable movers include ConocoPhillips (COP) at USD 124.65 with a 2% sell and 98% buy order split, Centrus Energy Corp (LEU) at USD 158.21 with 75% sell and 25% buy, and Phillips 66 (PSX) at USD 256.90 with 6% sell and 94% buy activity. Typical hold times range from 30 to 79 days on Pluang.
A Vice President at WM sold 1,365 shares valued at $300,000. Insider sales like this can indicate the executive's personal financial decisions but do not necessarily reflect the company's outlook. Investors should watch for any further insider activi...
The Florida Chamber of Commerce launched a billboard campaign in Chicago criticizing Illinois Governor JB Pritzker for policies they say are driving businesses and residents out of Illinois to Florida. The campaign highlights billions in taxable inco...
BMO Capital initiated coverage on Tenet Healthcare with a 'Market Perform' rating, indicating the stock is expected to perform in line with the broader market. The company is forecasted to report a 24.05% increase in Earnings Per Share (EPS) to $4.59...
The market experienced a downturn with significant losses among key stocks. New Fortress Energy dropped 24.7% amid ongoing volatility in energy sectors, while Xanadu Quantum Technologies fell 21.7% reflecting sensitivity in quantum stocks to commerci...
Jaguar Health (JAGX) surged over 1,150% after the FDA granted fee waivers for its drugs Mytesi and Canalevia-CA1, signaling regulatory support. Greenland Mines (GRML) rose nearly 50% amid growing investor interest linked to U.S.-Greenland security de...
